These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib. Voortman J; Resende TP; Abou El Hassan MA; Giaccone G; Kruyt FA Mol Cancer Ther; 2007 Jul; 6(7):2103-12. PubMed ID: 17620439 [TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis. Thorpe JA; Christian PA; Schwarze SR Prostate; 2008 Feb; 68(2):200-9. PubMed ID: 18076022 [TBL] [Abstract][Full Text] [Related]
9. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells. Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949 [TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
11. Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy. Sayers TJ; Murphy WJ Cancer Immunol Immunother; 2006 Jan; 55(1):76-84. PubMed ID: 15864587 [TBL] [Abstract][Full Text] [Related]
12. Melatonin as a proteasome inhibitor. Is there any clinical evidence? Vriend J; Reiter RJ Life Sci; 2014 Oct; 115(1-2):8-14. PubMed ID: 25219883 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism. Bullenkamp J; Raulf N; Ayaz B; Walczak H; Kulms D; Odell E; Thavaraj S; Tavassoli M Cell Death Dis; 2014 Oct; 5(10):e1489. PubMed ID: 25341043 [TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions. Kahana S; Finniss S; Cazacu S; Xiang C; Lee HK; Brodie S; Goldstein RS; Roitman V; Slavin S; Mikkelsen T; Brodie C Cell Signal; 2011 Aug; 23(8):1348-57. PubMed ID: 21440622 [TBL] [Abstract][Full Text] [Related]
15. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells. Lashinger LM; Zhu K; Williams SA; Shrader M; Dinney CP; McConkey DJ Cancer Res; 2005 Jun; 65(11):4902-8. PubMed ID: 15930312 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways. Seki N; Toh U; Sayers TJ; Fujii T; Miyagi M; Akagi Y; Kusukawa J; Kage M; Shirouzu K; Yamana H Mol Cancer Ther; 2010 Jun; 9(6):1842-51. PubMed ID: 20515944 [TBL] [Abstract][Full Text] [Related]
17. Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis. Unterkircher T; Cristofanon S; Vellanki SH; Nonnenmacher L; Karpel-Massler G; Wirtz CR; Debatin KM; Fulda S Clin Cancer Res; 2011 Jun; 17(12):4019-30. PubMed ID: 21525171 [TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Ganten TM; Koschny R; Haas TL; Sykora J; Li-Weber M; Herzer K; Walczak H Hepatology; 2005 Sep; 42(3):588-97. PubMed ID: 16037944 [TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Nikrad M; Johnson T; Puthalalath H; Coultas L; Adams J; Kraft AS Mol Cancer Ther; 2005 Mar; 4(3):443-9. PubMed ID: 15767553 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. Yang TM; Barbone D; Fennell DA; Broaddus VC Am J Respir Cell Mol Biol; 2009 Jul; 41(1):14-23. PubMed ID: 19097992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]